Back to Screener

Medtronic plc (MDT)

Price$81.67
Value ScoreB
Growth ScoreC
Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-30.39%
Price vs S&P 500 (4W)7.26%
VGM Score54.68
Market Capitalization$104.85B
P/E Ratio (Annual)21.84x
Indicated Dividend Yield (Annual)3.52%

All Metrics

P/CF (Annual)14.30x
Book Value / Share (Quarterly)$38.17
P/TBV (Annual)2.97x
Indicated Dividend (Annual)$2.84
Revenue Growth (3Y)5.21%
Cash Flow / Share (Quarterly)$4.21
Payout Ratio (TTM)75.78%
Price vs S&P 500 (YTD)-23.14%
Gross Margin (TTM)65.32%
Net Profit Margin (TTM)13.21%
EPS (TTM)$3.73
10-Day Avg Trading Volume14.37M
EPS Excl Extra (TTM)$3.73
Revenue Growth (5Y)3.84%
EPS (Annual)$3.73
Dividend / Share (Annual)$2.77
ROI (Annual)6.09%
Gross Margin (Annual)65.38%
Net Profit Margin (5Y Avg)13.28%
Cash / Share (Quarterly)$6.53
P/E Basic Excl Extra (TTM)21.84x
Revenue Growth QoQ (YoY)9.86%
EPS Growth (5Y)6.95%
P/E Normalized (Annual)21.84x
ROA (Last FY)5.09%
Revenue Growth TTM (YoY)8.43%
EBITD / Share (TTM)$6.40
ROE (5Y Avg)8.19%
Operating Margin (TTM)17.79%
Cash Flow / Share (Annual)$4.04
P/B Ratio2.14x
P/B Ratio (Quarterly)2.64x
Net Income / Employee (Annual)$50,500
EV / Revenue (TTM)3.71x
Net Interest Coverage (TTM)9.58x
ROA (TTM)5.05%
EPS Growth QoQ (YoY)17.56%
EV / EBITDA (TTM)16.56x
EPS Incl Extra (Annual)$3.73
Current Ratio (Annual)1.85x
Quick Ratio (Quarterly)1.87x
3-Month Avg Trading Volume9.59M
52-Week Price Return-6.13%
EV / Free Cash Flow (Annual)24.28x
P/E Incl Extra (TTM)21.84x
Revenue / Employee (TTM)$382,800
Tangible BV / Share (Quarterly)$30.12
P/S Ratio (Annual)2.88x
Asset Turnover (Annual)0.37x
52-Week High$106.33
Operating Margin (5Y Avg)17.40%
EPS Excl Extra (Annual)$3.73
CapEx CAGR (5Y)7.04%
Tangible BV CAGR (5Y)2.80%
26-Week Price Return-22.46%
Quick Ratio (Annual)1.42x
13-Week Price Return-12.19%
Total Debt / Equity (Annual)0.59x
Current Ratio (Quarterly)2.54x
Enterprise Value$131.78B
Revenue / Share Growth (5Y)4.88%
Asset Turnover (TTM)0.39x
Book Value / Share Growth (5Y)-0.20%
Revenue / Employee (Annual)$382,800
Inventory Turnover (Annual)2.17x
Pretax Margin (Annual)16.87%
Cash / Share (Annual)$6.99
3-Month Return Std Dev26.67%
Gross Margin (5Y Avg)66.20%
Net Income / Employee (TTM)$50,500
EBITDA CAGR (5Y)6.69%
EBITDA Interim CAGR (5Y)2.16%
ROE (Last FY)9.71%
Net Interest Coverage (Annual)10.96x
EPS Basic Excl Extra (Annual)$3.73
P/FCF (TTM)19.32x
Receivables Turnover (TTM)5.69x
EV / Free Cash Flow (TTM)24.28x
Total Debt / Equity (Quarterly)0.57x
EPS Incl Extra (TTM)$3.73
Receivables Turnover (Annual)5.31x
ROI (TTM)6.00%
Dividend Growth Rate (5Y)5.10%
P/S Ratio (TTM)2.88x
Pretax Margin (5Y Avg)16.64%
Revenue / Share (Annual)$28.23
Tangible BV / Share (Annual)$28.36
Forward P/E12.19x
Free OCF CAGR (5Y)2.13%
Price vs S&P 500 (52W)-30.49%
P/E Ratio (TTM)21.84x
EPS Growth TTM (YoY)3.07%
Year-to-Date Return-14.98%
5-Day Price Return10.39%
EPS Normalized (Annual)$3.73
ROA (5Y Avg)4.54%
Net Profit Margin (Annual)13.20%
Month-to-Date Return10.65%
Cash Flow / Share (TTM)$4.77
EBITD / Share (Annual)$6.40
EPS Growth (3Y)9.75%
Operating Margin (Annual)17.78%
LT Debt / Equity (Annual)0.53x
P/CF (TTM)14.30x
ROI (5Y Avg)5.43%
P/E Excl Extra (TTM)21.84x
LT Debt / Equity (Quarterly)0.57x
EPS Basic Excl Extra (TTM)$3.73
P/TBV (Quarterly)3.35x
Payout Ratio (Annual)75.81%
P/B Ratio (Annual)2.25x
Dividend / Share (TTM)$2.83
Inventory Turnover (TTM)2.07x
Pretax Margin (TTM)16.88%
Book Value / Share (Annual)$37.46
Price vs S&P 500 (13W)-20.45%
Net Margin Growth (5Y)1.98%
Dividend Yield (TTM)3.47%
Beta0.56x
P/FCF (Annual)19.32x
Revenue / Share (TTM)$28.23
ROE (TTM)9.54%
52-Week Low$73.31
vGradeB
gGradeC
mGradeC
vgmGradeC
Show chart for

Earnings Surprise History

Q4 261.55est. 1.56

Analyst Recommendations

Mar 2026
Apr 2026
May 2026
Jun 2026
3.82
3.81
3.81
3.76

Industry Peers — Electromedical Equipment(31)

About

Medtronic is one of the world's largest medical device manufacturers, offering a diversified portfolio of therapeutic devices for chronic diseases including cardiac, spinal, neurovascular, and surgical applications. The company's product lines span pacemakers and defibrillators, transcatheter heart valves, spinal fixation systems, ablation technologies, and advanced surgical tools. It serves healthcare institutions and physicians across the United States, Western Europe, and Japan, with approximately 50% of revenue derived from international markets.